Abstract: A printer that uses a number of control state machines to reconfigure logic array circuitry to perform image data processing in preparation for printing. The logic array circuitry is programmable and adaptable to accommodate a wide variety of printer components characteristic to digital image printing systems. The logic array circuitry is reconfigured, depending on the particular printer in which the invention is implemented, by the control state machines as they receive control state machine conditions corresponding to the printer components characteristic to that specific digital image printer. For example, the physical, mechanical, and electrical characteristics of the printer constitute the printer component that modify the control state machine conditions which in turn govern the configuration of the logic array circuitry through the control state machines.

Abstract: Operation of a video cassette player is facilitated by providing a VBI decoder which decodes information, such as title, channel, date, time and length of broadcast programs and utilizing the information in providing directory of the programs as well as control of the VCR. The video cassette player is also provided with a VBI encoder for inserting control as well as directory information into the tape, either in the VBI portions of the video track or in the control track.

Abstract: An input device comprising a fixed light source, a plurality of light detectors surrounding the light source, and a member comprising reflective surface portions slidably mounted above the light source. When the member is slid from a neutral position to one of a plurality of activating position, light from the light source is reflected by one of the reflective surface portions directly from the light source to an associated light detector.

Abstract: An ink cartridge with ink level indication for containing dispensable ink is disclosed. The ink cartridge includes a cartridge body and a reservoir for receiving and storing ink within the cartridge body. The reservoir is filled with a porous material member. A window is supported by the cartridge body to be disposed adjacent the porous material member. The window interacts with the porous material member to define porous material member portions of predetermined increasing capillarities. Each portion is able to retain ink therein for viewing through the window depending on its capillarity and the amount of ink in the reservoir to thereby provide an overall indication of the amount of ink in the print cartridge.

Abstract: A retroviral protease inhibiting compound of the formula: 1

Abstract: A sanitary napkin has a strip that extends rearwardly to reside in the intergluteal crevice. The pad fits snugly against the body without penetrating. Because the strip provides improved body contact, similar protection is achieved with a smaller pad, thus providing a discretion benefit to the wearer.

Abstract: A method of fabricating laminate assemblies determines the ideal weight (W) of underfill to be dispensed, based on the size of the semiconductor die and the gap between the die and the laminate substrate. Underfill is dispensed in a single step in an amount between 1.1W and 1.3W to form fillets that cover at least 15% of the height of the semiconductor die on all four sides of the die. The amount of underfill ensures that the fillet coverage imbalance is 30% or less for each of the pairs of opposing sides of the die, thereby improving solder joint reliability.

Abstract: Operation of a video cassette player is facilitated by providing a VBI decoder which decodes information, such as title, channel, date, time and length of broadcast programs and utilizing the information in providing directory of the programs as well as control of the VCR. The video cassette player is also provided with a VBI encoder for inserting control as well as directory information into the tape, either in the VBI portions of the video track or in the control track.

Abstract: Disclosed are methods for making immune system molecules, particularly humanized antibodies and fragments thereof. A typical method optimizes similarity between individual antibody framework regions to help identify human framework regions suitable for making the molecules. Comparisons between larger antibody frameworks, hypervariable domains or both is avoided. Also disclosed are antibodies that have been humanized by the method. The invention has a wide spectrum of applications including use in the production of humanized monoclonal antibodies with suitable binding affinity and minimized human immunogenicity.

Abstract: In some embodiments, the invention includes a system having first and second modules; and a circuit board including first and second module connectors to receive the first and second modules, respectively. The system also includes a first clock path of conductors to carry a first clock signal to first, second, third, and fourth chips on the first module and then to first, second, third, and fourth chips on the second module; and a second clock path of conductors to carry a second clock signal to the first, second, third, and fourth chips on the second module and then to the first, second, third, and fourth chips on the first module.

Abstract: A local driver circuit to drive a logic voltage at an output pad includes an adder having K bits to add a K-bit control value to a local value, the adder producing a K-bit calibrated value. The circuit further includes K field-effect transistors (FETs), the drain of each FET being coupled to the output pad, and logic circuitry to perform a logical-AND function between a data input and the K-bit calibrated value. The logic circuitry providing a K-bit output with each of the K output bits being coupled to the gate of a corresponding one of the FETs. A comparator produces a correction value from a comparison of the logic voltage at the output pad and a reference voltage. A control unit sets a least significant bit (LSB) portion of the local value responsive to the correction value so as to make the logic voltage at the output pad in the reference voltage substantially equal.

Abstract: A colorful pattern lighting structure comprises a core wire, a light string which is formed by a plurality of miniature bulbs sequentially connecting each other, multi-sectional thermal shrink membranes of different colors being sequentially disposed along the outside of the core wire, and a housing provided on the thermal shrink membranes. The present invention employs a structure of providing color thermal shrink membranes onto a core wire in order to conveniently form a colorful lighting string in accordance with the desired pattern. It successfully overcomes the problem existing in the conventional colorful lighting which needs to trim the wires and rearrange the connecting devices, thereby saving costs, reducing manufacturing procedures, ensuring waterproof, achieving high reliability. In addition, the present invention can ensure a uniform color on the lighting. The gap between two colors is considerably small in order to obtain a lighting string having high-density and changeable color combination.

Abstract: Disclosed is a method for preventing or treating thrombosis in a mammal such as a primate and particularly a human patient. A preferred method includes administering to the mammal a therapeutically effective amount of at least one humanized antibody, chimeric antibody, or fragment thereof that binds specifically to human tissue factor (TF). Additional methods and kits are provided.

Abstract: The present invention describes the preparation and use of biologically and immunologically active humanized monoclonal antibodies to Shiga toxin, a toxin associated with HC and the potentially life-threatening sequela HUS transmitted by strains of pathogenic bacteria. The present invention describes how these humanized antibodies may be used in the treatment or prevention of Shiga toxin induced diseases. One aspect of the invention is the humanized monoclonal antibody which binds Shiga toxin where the constant regions are IgG1-kappa and the variable regions are murine in origin. Yet another aspect of the invention is expression vectors and host cells transformed with such vectors which express the humanized monoclonal antibodies of the present invention.

Abstract: The present invention relates to polyspecific binding molecules and particularly single-chain polyspecific binding molecules that include at least one single-chain T-cell receptor (sc-TCR) covalently linked through a peptide linker sequence to at least one single-chain antibody (sc-Ab). Further disclosed are methods and compositions for testing and using the molecules.

Abstract: A method, system, and device capable of generating one or more clocks internally to detect, sample, and receive synchronous data streams and eliminate the need for corresponding external synchronization clocks for each data stream. One aspect of the clock generator provides a two-stage interpolation system. In a first stage, two clocks are selected which accurately detect a calibration data sample. In a second stage, a single, fine-tuned, clock is synthesized by interpolating the two selected clocks.

Abstract: This invention provides a solid-state lighting array driving circuit in which a plurality of solid-state lighting devices such as LEDs are rearranged in a reconfigurable circuit. The circuit may be changed to incorporate the LEDs into a larger or fewer number of parallel circuits each containing less or more LEDs themselves respectively. The reconfiguration may be done as a result of variable input voltages such that the circuit may reconfigure to provide a preferred number of LEDs in each circuit for the sensed voltage in the circuit.

Abstract: Compounds having the formula 1

Abstract: The present invention encompasses monoclonal and chimeric antibodies that bind to lipoteichoic acid of Gram positive bacteria. The antibodies also bind to whole bacteria and enhance phagocytosis and killing of the bacteria in vitro and enhance protection from lethal infection in vivo. The mouse monoclonal antibody has been humanized and the resulting chimeric antibody provides a previously unknown means to diagnose, prevent and/or treat infections caused by gram positive bacteria bearing lipoteichoic acid. This invention also encompasses a peptide mimic of the lipoteichoic acid epitope binding site defined by the monoclonal antibody. This epitope or epitope peptide mimic identifies other antibodies that may bind to the lipoteichoic acid epitope. Moreover, the epitope or epitope peptide mimic provides a valuable substrate for the generation of vaccines or other therapeutics.

Abstract: A buffer for use in a logic circuit comprises input and output nodes. A first inverter having a first device size is coupled to the input node. A second inverter is coupled in series with the first inverter and with the output node. The second inverter having a second device size at least six times greater than the first device size. It is emphasized that this abstract is provided to comply with the rules requiring an abstract that will allow a searcher or other reader to quickly ascertain the subject matter of the technical disclosure. It is submitted with the understanding that it will not be used to interpret or limit the scope or meaning of the claims. 37 CFR 1.72(b).